NATERA, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
NATERA, INC. (NTRA) had Debt Securities, Available-for-sale, Unrealized Loss Position of $11.97 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2025-08-08
- 2025-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $11.97M.
- 2025-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $17.83M.
- 2024-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $17.69M.
- 2024-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $27.99M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2025-06-30 | $11.97M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $17.83M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $17.69M 10-K · filed 2025-02-28 |
| 2024-09-30 | $27.99M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $90.30M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $65.69M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $115.37M 10-K · filed 2024-02-29 |
| 2023-09-30 | $267.85M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $351.82M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $408.86M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $430.79M 10-K · filed 2023-03-01 |
| 2021-12-31 | $604.70M 10-K · filed 2022-02-25 |
| 2020-12-31 | $144.00M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |